Dachengqitang mitigates endoscopic retrograde cholangiopancreatography-induced pancreatitis

Figure 6 In vivo studies have shown that Dachengqitang leads to the upregulation of Arg-1 and IL-10. A-J: Immunofluorescence staining showing Arg-1 expression in intestinal tissues across control, diabetes, and Dachengqitang (DCQT) treatment groups; K-T: Immunofluorescence staining displaying IL-10 expression levels across different experimental groups. Diabetes induction significantly decreased Arg-1 and IL-10 fluorescence intensity, while DCQT treatment restored their expression levels DCQT. The images are accompanied by a scale bar of 50 μm. ^aP < 0.05. DCQT: Dachengqitang.